These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23316297)

  • 1. Peroxiredoxin 4, a novel circulating biomarker for oxidative stress and the risk of incident cardiovascular disease and all-cause mortality.
    Abbasi A; Corpeleijn E; Postmus D; Gansevoort RT; de Jong PE; Gans RO; Struck J; Schulte J; Hillege HL; van der Harst P; Peelen LM; Beulens JW; Stolk RP; Navis G; Bakker SJ
    J Am Heart Assoc; 2012 Oct; 1(5):e002956. PubMed ID: 23316297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum peroxiredoxin 4: a marker of oxidative stress associated with mortality in type 2 diabetes (ZODIAC-28).
    Gerrits EG; Alkhalaf A; Landman GW; van Hateren KJ; Groenier KH; Struck J; Schulte J; Gans RO; Bakker SJ; Kleefstra N; Bilo HJ
    PLoS One; 2014; 9(2):e89719. PubMed ID: 24586984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating peroxiredoxin 4 and type 2 diabetes risk: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study.
    Abbasi A; Corpeleijn E; Gansevoort RT; Gans RO; Struck J; Schulte J; Hillege HL; van der Harst P; Stolk RP; Navis G; Bakker SJ
    Diabetologia; 2014 Sep; 57(9):1842-9. PubMed ID: 24893865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma N-terminal Prosomatostatin and Risk of Incident Cardiovascular Disease and All-Cause Mortality in a Prospective Observational Cohort: the PREVEND Study.
    Abbasi A; Kieneker LM; Corpeleijn E; Gansevoort RT; Gans RO; Struck J; de Boer RA; Hillege HL; Stolk RP; Navis G; Bakker SJ
    Clin Chem; 2017 Jan; 63(1):278-287. PubMed ID: 28062624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating levels of peroxiredoxin 4 as a novel biomarker of oxidative stress in patients with sepsis.
    Schulte J; Struck J; Köhrle J; Müller B
    Shock; 2011 May; 35(5):460-5. PubMed ID: 21283059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copeptin and peroxiredoxin-4 independently predict mortality in patients with nonspecific complaints presenting to the emergency department.
    Nickel CH; Ruedinger J; Misch F; Blume K; Maile S; Schulte J; Köhrle J; Hartmann O; Giersdorf S; Bingisser R
    Acad Emerg Med; 2011 Aug; 18(8):851-9. PubMed ID: 21843221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals.
    Yeboah J; McClelland RL; Polonsky TS; Burke GL; Sibley CT; O'Leary D; Carr JJ; Goff DC; Greenland P; Herrington DM
    JAMA; 2012 Aug; 308(8):788-95. PubMed ID: 22910756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin autofluorescence, arterial stiffness and Framingham risk score as predictors of clinical outcome in chronic kidney disease patients: a cohort study.
    Mukai H; Svedberg O; Lindholm B; Dai L; Heimbürger O; Barany P; Anderstam B; Stenvinkel P; Qureshi AR
    Nephrol Dial Transplant; 2019 Mar; 34(3):442-448. PubMed ID: 29378035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Traditional Cardiovascular Risk Factors Strongly Underestimate the 5-Year Occurrence of Cardiovascular Morbidity and Mortality in Spinal Cord Injured Individuals.
    Barton TJ; Low DA; Bakker EA; Janssen T; de Groot S; van der Woude L; Thijssen DHJ
    Arch Phys Med Rehabil; 2021 Jan; 102(1):27-34. PubMed ID: 32861666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple inflammatory biomarkers in relation to cardiovascular events and mortality in the community.
    Schnabel RB; Yin X; Larson MG; Yamamoto JF; Fontes JD; Kathiresan S; Rong J; Levy D; Keaney JF; Wang TJ; Murabito JM; Vasan RS; Benjamin EJ
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1728-33. PubMed ID: 23640499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating gamma glutamyltransferase and prediction of cardiovascular disease.
    Kunutsor SK; Bakker SJ; Kootstra-Ros JE; Gansevoort RT; Dullaart RP
    Atherosclerosis; 2015 Feb; 238(2):356-64. PubMed ID: 25555268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteopontin is a strong predictor of incipient diabetic nephropathy, cardiovascular disease, and all-cause mortality in patients with type 1 diabetes.
    Gordin D; Forsblom C; Panduru NM; Thomas MC; Bjerre M; Soro-Paavonen A; Tolonen N; Sandholm N; Flyvbjerg A; Harjutsalo V; Groop PH;
    Diabetes Care; 2014 Sep; 37(9):2593-600. PubMed ID: 24969575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GlycA, a Pro-Inflammatory Glycoprotein Biomarker, and Incident Cardiovascular Disease: Relationship with C-Reactive Protein and Renal Function.
    Gruppen EG; Riphagen IJ; Connelly MA; Otvos JD; Bakker SJ; Dullaart RP
    PLoS One; 2015; 10(9):e0139057. PubMed ID: 26398105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoluminometric assay for quantification of peroxiredoxin 4 in human serum.
    Schulte J; Struck J; Bergmann A; Köhrle J
    Clin Chim Acta; 2010 Sep; 411(17-18):1258-63. PubMed ID: 20493180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble Vascular Cell Adhesion Molecules May be Protective of Future Cardiovascular Disease Risk: Findings from the PREVEND Prospective Cohort Study.
    Kunutsor SK; Bakker SJL; Dullaart RPF
    J Atheroscler Thromb; 2017 Aug; 24(8):804-818. PubMed ID: 28202840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty Acid Binding Protein-4 and Risk of Cardiovascular Disease: The Cardiovascular Health Study.
    Egbuche O; Biggs ML; Ix JH; Kizer JR; Lyles MF; Siscovick DS; Djoussé L; Mukamal KJ
    J Am Heart Assoc; 2020 Apr; 9(7):e014070. PubMed ID: 32248728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating total bilirubin and risk of incident cardiovascular disease in the general population.
    Kunutsor SK; Bakker SJ; Gansevoort RT; Chowdhury R; Dullaart RP
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):716-24. PubMed ID: 25593130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher Serum Sex Hormone-Binding Globulin Levels Are Associated With Incident Cardiovascular Disease in Men.
    Gyawali P; Martin SA; Heilbronn LK; Vincent AD; Jenkins AJ; Januszewski AS; Adams RJT; O'Loughlin PD; Wittert GA
    J Clin Endocrinol Metab; 2019 Dec; 104(12):6301-6315. PubMed ID: 31390027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stress markers predict mortality in patients with nonspecific complaints presenting to the emergency department and may be a useful risk stratification tool to support disposition planning.
    Nickel CH; Messmer AS; Geigy N; Misch F; Mueller B; Dusemund F; Hertel S; Hartmann O; Giersdorf S; Bingisser R
    Acad Emerg Med; 2013 Jul; 20(7):670-9. PubMed ID: 23859580
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.